--- title: "Qianhong Bio-pharma (002550.SZ) — 财务报表" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/002550.SZ/norm.md" symbol: "002550.SZ" name: "Qianhong Bio-pharma" parent: "https://longbridge.com/zh-CN/quote/002550.SZ.md" datetime: "2026-03-14T10:05:39.187Z" locales: - [en](https://longbridge.com/en/quote/002550.SZ/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/002550.SZ/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/002550.SZ/norm.md) --- > 支持的语言: [English](https://longbridge.com/en/quote/002550.SZ/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002550.SZ/norm.md) # Qianhong Bio-pharma (002550.SZ) — 财务报表 ## 利润表 (CNY) | 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | EPS | 0.1001 | 0.0777 | 0.1288 | 0.0350 | 0.1015 | | ROE | 18.63% | 14.64% | 24.78% | 7.44% | 21.04% | | Revenue | 353.24M | 410.89M | 450.88M | 318.64M | 352.01M | | Net income | 125.18M | 97.08M | 160.97M | 46.45M | 126.79M | | Operating income | 203.55M | 39.53M | 181.60M | -57.10M | 143.08M | | Gross margin | 61.13% | 58.42% | 54.40% | 55.74% | 57.21% | | Net margin | 35.44% | 23.63% | 35.70% | 14.58% | 36.02% | | Profit quality | 139.89% | 53.19% | 253.95% | -89.27% | 85.90% | ## 资产负债表 (CNY) | 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | A&L | 3.02B | 2.87B | 2.95B | 2.83B | 2.76B | | Leverage | 1.09 | 1.10 | 1.10 | 1.12 | 1.11 | | BVPS | 2.20 | 2.10 | 2.14 | 2.01 | 1.98 | | Turnover | 0.5309 | 0.5570 | 0.5341 | 0.5454 | 0.5657 | | Cash & STI | 1.05B | 1.02B | 842.15M | 906.67M | 708.52M | | Inv & Rec | 382.97M | 357.93M | 367.04M | 426.81M | 390.77M | | LT assets | 547.36M | 544.00M | 549.30M | 563.60M | 524.47M | | Net debt | -1.05B | -999.00M | -822.13M | -885.19M | -688.50M | ## 现金流量表 (CNY) | 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | Operating CF | 145.51M | 74.32M | 71.51M | 63.96M | 166.56M | | Investing CF | -321.68M | 52.19M | 127.99M | -264.45M | -75.32M | | Financing CF | 5.01M | -150.76M | -676735.00 | 394431.00 | 2.81M | | Free CF | -2.59M | 229.34M | -176.51M | 61.06M | 52.00M | | OCF coverage | 414.90% | 38.99% | 332.58% | 106.06% | 1360.10% | | Repaid & issued | - | - | - | 4.69M | - | | CapEx | -15.58M | -39.88M | -20.83M | -55.69M | -12.05M | ## 分红方案 **股息率**: 1.56 ### 分红历史 | 描述 | 登记日 | 除息日 | 付息日 | |-------------|-------------|---------|--------------| | Cash Dividend: 0.117187CNY | 2025-05-28 | 2025-05-29 | 2025-05-29 | | Cash Dividend: 0.117187CNY | 2024-05-28 | 2024-05-29 | 2024-05-29 | | Cash Dividend: 0.119531CNY | 2023-05-25 | 2023-05-26 | 2023-05-26 |